Alopecia Treatment Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
Growth Factors of Alopecia Treatment Market
The Alopecia Treatment Market size was valued at USD 8,894.8 million in 2019 and is projected to reach USD 16,101.8 million by 2032, exhibiting a CAGR of 4.5% during the forecast period of 2024-2032.
The COVID-19 pandemic extensively impacted the alopecia treatment marketplace due to disruptions in healthcare services and supply chains. Additionally, economic uncertainty brought about reduced spending on non-crucial treatments, affecting the demand for hair healing healing procedures. However, as lockdowns eased, there has been a rebound in call for pushed thru expanded attention of health and private look, alongside a upward push in telemedicine offerings, allowing sufferers to are attempting to find on line consultations and get right of entry to treatments remotely. The marketplace has often recovered as normalcy again, showing renewed boom.
One of the cutting-edge trends within the alopecia treatment marketplace is the developing adoption of Platelet-Rich Plasma (PRP) remedy. It is preferred because of its safety profile, decreased chance of aspect results, and promising clinical outcomes. PRP treatment is often combined with one of a kind treatments like minoxidil or hair transplants to beautify efficacy. The growing call for for non-surgical and herbal-searching hair recovery alternatives has made PRP a preferred choice among patients and practitioners alike.
The growing occurrence of alopecia, mainly androgenetic alopecia and alopecia areata, is a substantial the use of issue within the marketplace. Factors like stress, hormonal imbalances, genetics, and way of lifestyles modifications make a contribution to hair loss, affecting every ladies and men. Hair loss often ends in intellectual misery, impacting self-esteem and quality of existence. This growing cognizance of the mental effect of hair loss has introduced about a surge in demand for effective treatments. As human beings are seeking for answers to decorate their look and intellectual well-being, the market for alopecia remedy continues to extend, pushed with the resource of a choice for progressed aesthetic results.
Comprehensive Analysis of Alopecia Treatment Market
The Alopecia Treatment Market growth is rising at an exponential rate due to its marketplace segmentation. This market expansion correctly affords a detailed local assessments thinking about the dominant supply and call for forces that effect the enterprise. These segmentations are methodically segregated by route of administration, by gender type, by age group, by end user . By Route of Administration include Topical, Injectable, Oral. By Gender Type include Male, Female. By Age Group include Below 18 years, 18 - 34 Years ,35 - 49 Years, Above 50 Years. By End User include Hospitals and Physicians offices, Dermatology Clinics, Others.
The Asia Pacific location lead the Alopecia Treatment Market share percentage via benefitting a marketplace size of USD 3,114.14 million High growth is owing to the growing prevalence of alopecia in the region.
The top players in the market play a crucial role in the industry assuring market growth and setting market standards. These players include, Google LLC (Alphabet, Inc.), Magic Leap, Inc., ReWalk Robotics, SAMSUNG, B-Temia, Panasonic Holdings Corporation, NVIDIA Corporation, Microsoft, Ekso Bionics, Vuzix,these market players provide a level-playing competitive landscape.
January 2021 – Follicum AB announced that they have got finished the Phase IIa examine for their product FOL-0.5 for the remedy of sufferers struggling with hair loss. The trial changed into conducted on 2 hundred male sufferers to have a look at the protection and efficacy of various doses of this drug.
Segmentation Table
ATTRIBUTE DETAILS
Study Period 2016-2027
Base Year 2019
Forecast Period 2020-2027
Historical Period 2016-2018
Unit Value (USD million)
SegmentationBy Route of Administration
Topical
Injectable
Oral
By Gender Type
Male
Female
By Age Group
Below 18 years
18 - 34 Years
35 - 49 Years
Above 50 Years
By End User
Hospitals and Physicians offices
Dermatology Clinics
Others
By Geography
North America (the U.S. and Canada)
Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe)
Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia- Pacific)
Latin America (Brazil, Mexico, and the Rest of Latin America)
The Middle East & Africa (South Africa, GCC and the Rest of Middle East & Africa)
Please Note: It will take 5-6 business days to complete the report upon order confirmation.
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 4. Key Insights
- 4.1. Recent Industry Developments Such as Mergers & Acquisitions
- 4.2. Insights on Funding Scenario Pertaining to Research and Development of Alopecia Drugs
- 4.3. Product Pipeline Analysis
- 4.4. Industry Background Pertaining to Alopecia Treatment Solutions
- 4.5. Key Industry Trends
- 4.6. New Product Launch
- 5. Global Alopecia Treatment Market Analysis, Insights and Forecast, 2016-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Route of Administration
- 5.2.1. Topical
- 5.2.2. Injectable
- 5.2.3. Oral
- 5.3. Market Analysis, Insights and Forecast – By Gender Type
- 5.3.1. Male
- 5.3.2. Female
- 5.4. Market Analysis, Insights and Forecast – By Age Group
- 5.4.1. Below 18 years
- 5.4.2. 18 - 34 Years
- 5.4.3. 35 - 49 Years
- 5.4.4. Above 50 Years
- 5.5. Market Analysis, Insights and Forecast – By End User
- 5.5.1. Hospitals and Physician offices
- 5.5.2. Dermatology Clinics
- 5.5.3. Others
- 5.6. Market Analysis, Insights and Forecast – By Region
- 5.6.1. North America
- 5.6.2. Europe
- 5.6.3. Asia Pacific
- 5.6.4. Latin America
- 5.6.5. Middle East & Africa
- 6. North America Alopecia Treatment Market Analysis, Insights and Forecast, 2016-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Route of Administration
- 6.2.1. Topical
- 6.2.2. Injectable
- 6.2.3. Others
- 6.3. Market Analysis, Insights and Forecast – By Gender Type
- 6.3.1. Male
- 6.3.2. Female
- 6.4. Market Analysis, Insights and Forecast – By Age Group
- 6.4.1. Below 18 years
- 6.4.2. 18 - 34 Years
- 6.4.3. 35 - 49 Years
- 6.4.4. Above 50 Years
- 6.5. Market Analysis, Insights and Forecast – By End User
- 6.5.1. Hospitals and Physician offices
- 6.5.2. Dermatology Clinics
- 6.5.3. Others
- 6.6. Market Analysis, Insights and Forecast - By Country
- 6.6.1. U.S.
- 6.6.2. Canada
- 7. Europe Alopecia Treatment Market Analysis, Insights and Forecast, 2016-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Route of Administration
- 7.2.1. Topical
- 7.2.2. Injectable
- 7.2.3. Others
- 7.3. Market Analysis, Insights and Forecast – By Gender Type
- 7.3.1. Male
- 7.3.2. Female
- 7.4. Market Analysis, Insights and Forecast – By Age Group
- 7.4.1. Below 18 years
- 7.4.2. 18 - 34 Years
- 7.4.3. 35 - 49 Years
- 7.4.4. Above 50 Years
- 7.5. Market Analysis, Insights and Forecast – By End User
- 7.5.1. Hospitals and Physician offices
- 7.5.2. Dermatology Clinics
- 7.5.3. Others
- 7.6. Market Analysis, Insights and Forecast - By Country/Sub Region
- 7.6.1. U.K.
- 7.6.2. Germany
- 7.6.3. France
- 7.6.4. Spain
- 7.6.5. Italy
- 7.6.6. Scandinavia
- 7.6.7. Rest of Europe
- 8. Asia Pacific Alopecia Treatment Market Analysis, Insights and Forecast, 2016-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Route of Administration
- 8.2.1. Topical
- 8.2.2. Injectable
- 8.2.3. Others
- 8.3. Market Analysis, Insights and Forecast – By Gender Type
- 8.3.1. Male
- 8.3.2. Female
- 8.4. Market Analysis, Insights and Forecast – By Age Group
- 8.4.1. Below 18 years
- 8.4.2. 18 - 34 Years
- 8.4.3. 35 - 49 Years
- 8.4.4. Above 50 Years
- 8.5. Market Analysis, Insights and Forecast – By End User
- 8.5.1. Hospitals and Physician offices
- 8.5.2. Dermatology Clinics
- 8.5.3. Others
- 8.6. Market Analysis, Insights and Forecast - By Country/Sub Region
- 8.6.1. Japan
- 8.6.2. China
- 8.6.3. India
- 8.6.4. Australia
- 8.6.5. Southeast Asia
- 8.6.6. Rest of Asia Pacific
- 9. Latin America Alopecia Treatment Market Analysis, Insights and Forecast, 2016-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Route of Administration
- 9.2.1. Topical
- 9.2.2. Injectable
- 9.2.3. Others
- 9.3. Market Analysis, Insights and Forecast – By Gender Type
- 9.3.1. Male
- 9.3.2. Female
- 9.4. Market Analysis, Insights and Forecast – By Age Group
- 9.4.1. Below 18 years
- 9.4.2. 18 - 34 Years
- 9.4.3. 35 - 49 Years
- 9.4.4. Above 50 Years
- 9.5. Market Analysis, Insights and Forecast – By End User
- 9.5.1. Hospitals and Physician offices
- 9.5.2. Dermatology Clinics
- 9.5.3. Others
- 9.6. Market Analysis, Insights and Forecast - By Country/Sub Region
- 9.6.1. Brazil
- 9.6.2. Mexico
- 9.6.3. Rest of Latin America
- 10. Middle East & Africa Alopecia Treatment Market Analysis, Insights and Forecast, 2016-2027
- 10.1. Key Findings / Summary
- 10.2. Market Analysis, Insights and Forecast – By Route of Administration
- 10.2.1. Topical
- 10.2.2. Injectable
- 10.2.3. Others
- 10.3. Market Analysis, Insights and Forecast – By Gender Type
- 10.3.1. Male
- 10.3.2. Female
- 10.4. Market Analysis, Insights and Forecast – By Age Group
- 10.4.1. Below 18 years
- 10.4.2. 18 - 34 Years
- 10.4.3. 35 - 49 Years
- 10.4.4. Above 50 Years
- 10.5. Market Analysis, Insights and Forecast – By End User
- 10.5.1. Hospitals and Physician offices
- 10.5.2. Dermatology Clinics
- 10.5.3. Others
- 10.6. Market Analysis, Insights and Forecast - By Country/Sub Region
- 10.6.1. GCC Countries
- 10.6.2. South Africa
- 10.6.3. Rest of Middle East & Africa
- 11. Competitive Analysis
- 11.1. Key Industry Developments
- 11.2. Global Market Share Analysis (2019)
- 11.3. Competition Dashboard
- 11.4. Comparative Analysis – Major Players
- 11.5. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))
- 11.5.1. Aclaris Therapeutics, Inc.
- 11.5.1.1. Overview,
- 11.5.1.2. Products & services,
- 11.5.1.3. SWOT analysis,
- 11.5.1.4. Recent developments,
- 11.5.1.5. strategies,
- 11.5.1.6. financials (based on availability)
- 11.5.2. Follicum AB
- 11.5.2.1. Overview,
- 11.5.2.2. Products & services,
- 11.5.2.3. SWOT analysis,
- 11.5.2.4. Recent developments,
- 11.5.2.5. strategies,
- 11.5.2.6. financials (based on availability)
- 11.5.3. Fagron
- 11.5.3.1. Overview,
- 11.5.3.2. Products & services,
- 11.5.3.3. SWOT analysis,
- 11.5.3.4. Recent developments,
- 11.5.3.5. strategies,
- 11.5.3.6. financials (based on availability)
- 11.5.4. Concert Pharmaceuticals Inc.
- 11.5.4.1. Overview,
- 11.5.4.2. Products & services,
- 11.5.4.3. SWOT analysis,
- 11.5.4.4. Recent developments,
- 11.5.4.5. strategies,
- 11.5.4.6. financials (based on availability)
- 11.5.5. Sun Pharmaceutical Industries Ltd.
- 11.5.5.1. Overview,
- 11.5.5.2. Products & services,
- 11.5.5.3. SWOT analysis,
- 11.5.5.4. Recent developments,
- 11.5.5.5. strategies,
- 11.5.5.6. financials (based on availability)
- 11.5.6. Daiichi Sankyo
- 11.5.6.1. Overview,
- 11.5.6.2. Products & services,
- 11.5.6.3. SWOT analysis,
- 11.5.6.4. Recent developments,
- 11.5.6.5. strategies,
- 11.5.6.6. financials (based on availability)
- 11.5.7. Cipla Inc.
- 11.5.7.1. Overview,
- 11.5.7.2. Products & services,
- 11.5.7.3. SWOT analysis,
- 11.5.7.4. Recent developments,
- 11.5.7.5. strategies,
- 11.5.7.6. financials (based on availability)
- 11.5.8. Johnson & Johnson
- 11.5.8.1. Overview,
- 11.5.8.2. Products & services,
- 11.5.8.3. SWOT analysis,
- 11.5.8.4. Recent developments,
- 11.5.8.5. strategies,
- 11.5.8.6. financials (based on availability)
- 11.5.9. GlaxoSmithKline plc.
- 11.5.9.1. Overview,
- 11.5.9.2. Products & services,
- 11.5.9.3. SWOT analysis,
- 11.5.9.4. Recent developments,
- 11.5.9.5. strategies,
- 11.5.9.6. financials (based on availability)
- 11.5.10. Merck & Co., Inc.,
- 11.5.10.1. Overview,
- 11.5.10.2. Products & services,
- 11.5.10.3. SWOT analysis,
- 11.5.10.4. Recent developments,
- 11.5.10.5. strategies,
- 11.5.10.6. financials (based on availability)
- 12. Strategic Recommendations
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook